The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider Flynn Daniel Lee since year 2005.
The trader's CIK number is 1713712.
At the time of the last reporting, Flynn Daniel Lee was the Chief Scientific Officer of Deciphera Pharmaceuticals, Inc. .
(stock ticker symbol DCPH).
See this page for all insider trading activities at Deciphera Pharmaceuticals, Inc. .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2019-08-13||DCPH||Deciphera Pharmaceuticals, Inc.||Sale||148,107||41.50||6,145,996|
|2019-08-13||DCPH||Deciphera Pharmaceuticals, Inc.||Option Ex||123,107||1.89||232,672|
|2019-02-21||DCPH||Deciphera Pharmaceuticals, Inc.||Option Ex||24,500||3.95||96,775|
|2019-01-16||DCPH||Deciphera Pharmaceuticals, Inc.||Sale||152,629||26.00||3,968,354|
|2019-01-16||DCPH||Deciphera Pharmaceuticals, Inc.||Option Ex||152,629||1.89||288,468|
|2019-01-11||DCPH||Deciphera Pharmaceuticals, Inc.||Sale||300||26.00||7,800|
|2019-01-11||DCPH||Deciphera Pharmaceuticals, Inc.||Option Ex||300||1.89||567|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Flynn Daniel Lee (Chief Scientific Officer of Deciphera Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.